최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Cellular physiology and biochemistry, v.42 no.4, 2017년, pp.1603 - 1613
Xiao, Yunbin (Academy of Pediatrics, University of South China, Hengyang, China) , Peng, Hongyan (Institute of Pharmacy and Pharmacology, University of South China, Hengyang, China) , Hong, Chenliang (Institute of Pharmacy and Pharmacology, University of South China, Hengyang, China) , Chen, Zhi (Department of Cardiology, Hunan Children&apos) , Deng, Xicheng (s Hospital, Changsha, China) , Wang, Aiping (Department of Cardiology, Hunan Children&apos) , Yang, Fang (s Hospital, Changsha, China) , Yang, Li (Department of Anatomy, School of Medicine, University of South China, Hengyang, China) , Chen, Chen (Institute of Pharmacy and Pharmacology, University of South China, Hengyang, China) , Qin, Xuping (Institute of Pharmacy and Pharmacology, University of South China, Hengyang, China)
AbstractBackground/Aims: The enhanced proliferation of pulmonary arterial smooth muscle cells (PASMCs) is a central pathological component in pulmonary arterial hypertension (PAH). Both the Warburg effect and platelet-derived growth factor (PDGF) are involved in the proliferation of PASMCs. However,...
1. Noureddine H, Gary-Bobo G, Alifano M, Marcos E, Saker M, Vienney N, Amsellem V, Maitre B, Chaouat A, Chouaid C, Dubois-Rande JL, Damotte D, Adnot S: Pulmonary artery smooth muscle cell senescence is a pathogenic mechanism for pulmonary hypertension in chronic lung disease. Circ Res 2011; 109:543-553. 21719760 10.1161/CIRCRESAHA.111.241299
2. Chung WJ, Park YB, Jeon CH, Jung JW, Ko KP, Choi SJ, Seo HS, Lee JS, Jung HO: Baseline Characteristics of the Korean Registry of Pulmonary Arterial Hypertension. J Korean Med Sci 2015; 30:1429-1438. 26425039 10.3346/jkms.2015.30.10.1429
3. Koppenol WH, Bounds PL, Dang CV: Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 2011; 11:325-337. 21508971 10.1038/nrc3038
4. Vander Heiden MG, Cantley LC, Thompson CB: Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324:1029-1033. 19460998 10.1126/science.1160809
5. Paulin R, Michelakis ED: The metabolic theory of pulmonary arterial hypertension. Circ Res 2014; 115:148-164. 24951764 10.1161/CIRCRESAHA.115.301130
6. Rehman J, Archer SL: A proposed mitochondrial-metabolic mechanism for initiation and maintenance of pulmonary arterial hypertension in fawn-hooded rats: the Warburg model of pulmonary arterial hypertension. Adv Exp Med Biol 2010; 661: 171-185. 20204730 10.1007/978-1-60761-500-2_11
8. Theisen CS, Wahl JK 3rd, Johnson KR, Wheelock MJ: NHERF links the N-cadherin/catenin complex to the platelet-derived growth factor receptor to modulate the actin cytoskeleton and regulate cell motility. Mol Biol Cell 2007; 18: 1220-1232. 17229887 10.1091/mbc.E06-10-0960
9. Li L, Xu M, Li X, Lv C, Zhang X, Yu H, Zhang M, Fu Y, Meng H, Zhou J: Platelet- derived growth factor-B (PDGF-B) induced by hypoxia promotes the survival of pulmonary arterial endothelial cells through the PI3K/Akt/Stat3 pathway. Cell Physiol Biochem 2015; 35:441-451. 25613241 10.1159/000369709
10. Courtnay R, Ngo DC, Malik N, Ververis K, Tortorella SM, Karagiannis TC: Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K. Mol Biol Rep 2015; 42:841-851. 25689954 10.1007/s11033-015-3858-x
11. Yang X, Cheng Y, Li P, Tao J, Deng X, Zhang X, Gu M, Lu Q, Yin C: A lentiviral sponge for miRNA-21 diminishes aerobic glycolysis in bladder cancer T24 cells via the PTEN/PI3K/AKT/mTOR axis. Tumour Biol 2015; 36:383-391. 25266796 10.1007/s13277-014-2617-2
12. Cottrill KA, Chan SY: Metabolic dysfunction in pulmonary hypertension: the expanding relevance of the Warburg effect. Eur J Clin Invest 2013; 43:855-865. 23617881 10.1111/eci.12104
13. Archer SL, Gomberg-Maitland M, Maitland ML, Rich S, Garcia JG, Weir EK: Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF- 1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer. Am J Physiol Heart Circ Physiol 2008; 294:H570-578. 18083891 10.1152/ajpheart.01324.2007
14. Perez J, Hill BG, Benavides GA, Dranka BP, Darley-Usmar VM: Role of cellular bioenergetics in smooth muscle cell proliferation induced by platelet-derived growth factor. Biochem J 2010; 428:255-267. 20331438 10.1042/BJ20100090
15. Werle M, Kreuzer J, Hofele J, Elsasser A, Ackermann C, Katus HA, Vogt AM: Metabolic control analysis of the Warburg-effect in proliferating vascular smooth muscle cells. J Biomed Sci 2005; 12:827-834. 16205843 10.1007/s11373-005-9010-5
16. Houssaini A, Abid S, Mouraret N, Wan F, Rideau D, Saker M, Marcos E, Tissot CM, Dubois-Rande JL, Amsellem V, Adnot S: Rapamycin reverses pulmonary artery smooth muscle cell proliferation in pulmonary hypertension. Am J Respir Cell Mol Biol 2013; 48:568-577. 23470622 10.1165/rcmb.2012-0429OC
17. Chan SY, Loscalzo J: Pathogenic mechanisms of pulmonary arterial hypertension. J Mol Cell Cardiol 2008; 44:14-30. 17950310 10.1016/j.yjmcc.2007.09.006
18. Wang AP, Li XH, Yang YM, Li WQ, Zhang W, Hu CP, Zhang Z, Li YJ: A Critical Role of the mTOR/eIF2alpha Pathway in Hypoxia-Induced Pulmonary Hypertension. PLoS One 2015; 10:e0130806. 26120832 10.1371/journal.pone.0130806
19. Takahashi J, Orcholski M, Yuan K, de Jesus Perez V: PDGF-dependent beta-catenin activation is associated with abnormal pulmonary artery smooth muscle cell proliferation in pulmonary arterial hypertension. FEBS Lett 2016; 590:101-109. 26787464 10.1002/1873-3468.12038
20. Godinas L, Guignabert C, Seferian A, Perros F, Bergot E, Sibille Y, Humbert M, Montani D: Tyrosine kinase inhibitors in pulmonary arterial hypertension: a double-edge sword? Semin Respir Crit Care Med 2013; 34:714-724. 24037637 10.1055/s-0033-1356494
21. Dahal BK, Heuchel R, Pullamsetti SS, Wilhelm J, Ghofrani HA, Weissmann N, Seeger W, Grimminger F, Schermuly RT: Hypoxic pulmonary hypertension in mice with constitutively active platelet-derived growth factor receptor-beta. Pulm Circ 2011; 1:259-268. 22034611 10.4103/2045-8932.83448
22. Robey RB, Hay N: Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis. Semin Cancer Biol 2009; 19:25-31. 19130886 10.1016/j.semcancer.2008.11.010
23. Hitosugi T, Fan J, Chung TW, Lythgoe K, Wang X, Xie J, Ge Q, Gu TL, Polakiewicz RD, Roesel JL, Chen GZ, Boggon TJ, Lonial S, Fu H, Khuri FR, Kang S, Chen J: Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism. Mol Cell 2011; 44:864-877. 22195962 10.1016/j.molcel.2011.10.015
24. Sutendra G, Dromparis P, Bonnet S, Haromy A, McMurtry MS, Bleackley RC, Michelakis ED: Pyruvate dehydrogenase inhibition by the inflammatory cytokine TNFalpha contributes to the pathogenesis of pulmonary arterial hypertension. J Mol Med (Berl) 2011; 89:771-783. 21809123 10.1007/s00109-011-0762-2
25. Semenza GL: Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning. Biochim Biophys Acta 2011; 1813:1263-1268. 20732359 10.1016/j.bbamcr.2010.08.006
26. Peng H, Xiao Y, Deng X, Luo J, Hong C, Qin X: The Warburg effect: A new story in pulmonary arterial hypertension. Clin Chim Acta 2016; 461:53-58. 27475978 10.1016/j.cca.2016.07.017
27. Woo YM, Shin Y, Lee EJ, Lee S, Jeong SH, Kong HK, Park EY, Kim HK, Han J, Chang M, Park JH: Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF -1alpha Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells. PLoS One 2015; 10:e0132285. 26158266 10.1371/journal.pone.0132285
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.